| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
PLUS THERAPEUTICS, Inc. (NASDAQ:PSTV) shares are trading higher on Wednesday. The stock continues to gain after reporting third-quarter financial results on Tuesday.
What To Know: Plus Therapeutics released its third-quarter earnings report after the close of the market Tuesday. The company reported quarterly losses of $1.00 per share, above the analyst consensus estimate of losses of $1.12 per share. The figure represents a 64.91% increase over losses of $2.85 per share from the same period last year
Quarterly sales came in at $1.24 million, missing the analyst consensus estimate of $1.29 million, a 1,600% increase over sales of $73,000 from the same period last year.
Also on Tuesday, the company announced a share repurchase program to purchase up to $500,000 of common stock as well.
Related Link: Pfizer Analysts Cut Their Forecasts Following Q3 Results
PSTV Price Action: Shares of PSTV were up 5.08% at $1.28 at the time of publication, according to Benzinga Pro.
Image by Michal Jarmoluk from Pixabay
Posted In: PSTV
